Edge Pharma Announces New Agreement with Cardinal Health ’s Acuity™ GPO

Edge Pharma, a 503B Outsourcing Facility, has entered into an agreement with Cardinal Health’s Acuity™ GPO to provide its member ophthalmology practices with Edge’s unit-dose MVASI™ (Bevacizumab-awwb)...(PRWeb July 14, 2021)Read the full story at https://www.prweb.com/releases/edge_pharma_announces_new_agreement_with_cardinal_healths_acuity_gpo/prweb18065310.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news